NCT07909590
A Study Evaluating the Impact of a Painkiller Product on Quality-of-Life and Daily Functioning
Track this trial
Free. We email you which fields changed when ClinicalTrials.gov updates this record.
Record History
All 2 versions: 2 with changes below.
- Minor Start date pushed from Nov 2026 to Dec 2026
- Study First Submitted
- Minor: routine updates
Endpoints
Primary
Pain Intensity Before Using Panadol/Dolex
Timeframe: Within the past 1 month from time of participation
Perceived Relief From Panadol/Dolex Use
Timeframe: Within the past 1 month from time of participation
QoL Assessment After Using Panadol/Dolex Post Headache Episode
Timeframe: Within the past 1 month from time of participation
Secondary (8)
Frequency of Panadol/Dolex Use
Timepoint of Panadol/Dolex Use
Product Satisfaction
Headache Management Behaviors
User Attitudes Towards Panadol/Dolex: Trust in The Product
Show 3 moreShow less
User Attitudes Towards Panadol/Dolex: Value For Money
User Attitudes Towards Panadol/Dolex: Intention to Use Again
User Attitudes Towards Panadol/Dolex: Intention to Recommend Other Consumers
Arms and interventions
Panadol/Dolex Tablet
Participants who have taken Panadol/Dolex for at least 1 headache episode in the past 1 month.
Drugs: Paracetamol
Sites
1 site in 1 country
- Virtual siteSingapore, Marina Centre, Singapore